Following my October 20, 2021 Intuitive Surgical, Inc. stock analysis, the share price jumped from my ~$336 purchase price to ~$365 on November 8. Fortunately, the share price has recently pulled back. As far as I can tell, no news has led to this price fluctuation. With the share price having retraced to ~$340, I [...]
In my November 10, 2019, Stryker Corporation stock analysis I discuss SYK's agreement to acquire Wright Medical and disclose that I initiated a position in one of the 'Core' accounts within the FFJ Portfolio and in an account for which I do not disclose details. I followed up this post with another on November 15, [...]
On June 10, 2021, I initiated a 500 Rollins (ROL) shares position @ ~$33.15/share and explained my rationale for doing so in this Rollins stock analysis. I subsequently reviewed ROL's Q2 and YTD2021 results in my August 7th post. I now revisit ROL following the October 27th release of Q3 and YTD2021 results. Rollins - [...]
After my August 6, 2021, Becton Dickinson (BDX) stock analysis, the company: released Q4 and FY2021 results and FY2022 guidance on November 4; and held its 2021 virtual Investor Day on November 12. Investors who invest solely based on stock price performance will view BDX to be a poor investment. Looking at BDX's shareholder return [...]
This TMX Group Limited (X.to) stock analysis is the final post in my series of analyses of Financial Data & Stock Exchanges industry participants. Please click here to access previous posts. NOTE: All dollar values related to X are in $CAD. I view the Financial Data & Stock Exchanges industry as an attractive industry in [...]
Microsoft's dividend safety will appeal to investors who rely on dividend income and who have a low tolerance for risk. I encourage you to read my recently published Microsoft - (MSFT) 'AAA' Dividend Safety guest post at Dividend Power if your investor profile includes a low-risk tolerance. I wish you much success on your journey [...]
At the time of my November 11, 2020 post, Intact Financial Corporation (IFC) had just announced its intent to acquire RSA Insurance Group PLC with Tryg A/S. In that post, I disclose the purchase of additional IFC shares. I also wrote a guest post at Value of Stocks on February 14, 2021. After these posts, [...]
In my August 10, 2021 Viatris (VTRS) stock analysis I reviewed Q2 and YTD financial results and the company's valuation based on guidance. I now revisit VTRS following the November 8, 2021 release of Q3 and YTD 2021 results and revised FY2021 guidance. Viatris - Stock Analysis - Business Overview VTRS's FY2020 Form 10-K provides [...]
In my September 3, 2021 post I disclose the purchase of additional Mastercard Incorporated (MA) shares @ $340.3929/share in one of the 'Core' accounts in the FFJ Portfolio. On October 26, Visa (V) released Q4 and FY2021 results. The share price of both V and MA plunged so I acquired more shares in both companies [...]
In my February 8, 2021 Merck & Co., Inc. (MRK) stock analysis I disclosed that my findings led me to initiate a 300 share position in one of the 'Core' accounts in the FFJ Portfolio. I subsequently analyzed Q1 2021 results and FY2021 guidance in my May 3, 2021 MRK stock analysis and disclosed the [...]